We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
10 Year Est. Return
AUM
$572M
AUM Growth
+$505M
Cap. Flow
+$466M
Cap. Flow %
81.59%
Top 10 Hldgs %
75.29%
Holding
570
New
76
Increased
157
Reduced
78
Closed
237

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.22M
2
BIIB icon
Biogen
BIIB
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.04M
4
ROST icon
Ross Stores
ROST
+$1.53M
5
MNST icon
Monster Beverage
MNST
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 7.26%
2 Industrials 3.12%
3 Communication Services 2.93%
4 Financials 2.5%
5 Consumer Discretionary 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
101
PepsiCo
PEP
$189B
$377K 0.07%
2,219
+2,202
+12,953% +$365K
MTG icon
102
MGIC Investment
MTG
$6.24B
$371K 0.06%
19,235
+13,250
+221% +$235K
VRT icon
103
Vertiv
VRT
$108B
$367K 0.06%
7,644
+4,835
+172% +$206K
WWD icon
104
Woodward
WWD
$22.2B
$366K 0.06%
+2,688
New +$351K
AOS icon
105
A.O. Smith
AOS
$8.61B
$357K 0.06%
+4,333
New +$320K
VST icon
106
Vistra
VST
$47.4B
$354K 0.06%
9,191
+5,977
+186% +$208K
KDP icon
107
Keurig Dr Pepper
KDP
$42.1B
$354K 0.06%
10,625
+10,609
+66,306% +$331K
AFL icon
108
Aflac
AFL
$63.7B
$350K 0.06%
4,244
+4,221
+18,352% +$340K
ARES icon
109
Ares Management
ARES
$31.5B
$349K 0.06%
+2,937
New +$319K
CL icon
110
Colgate-Palmolive
CL
$74.2B
$347K 0.06%
+4,358
New +$328K
TOL icon
111
Toll Brothers
TOL
$14.5B
$342K 0.06%
3,330
+2,002
+151% +$167K
MDLZ icon
112
Mondelez International
MDLZ
$79.8B
$340K 0.06%
4,692
+1,726
+58% +$118K
CASY icon
113
Casey's General Stores
CASY
$31.7B
$337K 0.06%
+1,226
New +$335K
EXPD icon
114
Expeditors International
EXPD
$23.5B
$334K 0.06%
+2,628
New +$310K
MANH icon
115
Manhattan Associates
MANH
$11.1B
$329K 0.06%
1,530
+1,021
+201% +$216K
XPO icon
116
XPO
XPO
$23.5B
$327K 0.06%
3,728
+2,353
+171% +$192K
LII icon
117
Lennox International
LII
$15.5B
$320K 0.06%
+716
New +$286K
NUE icon
118
Nucor
NUE
$62.4B
$301K 0.05%
1,727
+1,718
+19,089% +$272K
INGR icon
119
Ingredion
INGR
$6.44B
$298K 0.05%
+2,750
New +$276K
DOX icon
120
Amdocs
DOX
$5.85B
$292K 0.05%
3,317
+3,297
+16,485% +$275K
DECK icon
121
Deckers Outdoor
DECK
$13.5B
$290K 0.05%
2,604
-1,044
-29% -$106K
PPG icon
122
PPG Industries
PPG
$26.3B
$287K 0.05%
1,919
+1,906
+14,662% +$258K
EFA icon
123
iShares MSCI EAFE ETF
EFA
$79.5B
$282K 0.05%
3,748
+3,642
+3,436% +$257K
IEV icon
124
iShares Europe ETF
IEV
$1.69B
$282K 0.05%
5,338
+5,205
+3,914% +$256K
WST icon
125
West Pharmaceutical
WST
$24.7B
$281K 0.05%
799
+170
+27% +$60.2K

Similar funds

USA Financial Formulas's Q4 2023 Portfolio in Review

As of Q4 2023, USA Financial Formulas held 570 positions worth $572M, up 754% from $66.9M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

USA Financial Formulas deployed $466M of net new capital in Q4 2023, opening 76 new positions and adding to 157 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 17% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Biogen, an estimated $2.09M trimmed.

  • USA Financial Formulas's largest Q4 2023 buy was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.
  • USA Financial Formulas added most to iShares S&P Mid-Cap 400 Growth ETF in Q4 2023, an estimated $61.8M increase.
  • USA Financial Formulas's biggest Q4 2023 reduction was Biogen, cutting an estimated $2.09M.
  • USA Financial Formulas fully exited Regeneron Pharmaceuticals in Q4 2023, selling an estimated $2.22M.
  • USA Financial Formulas's ten largest holdings make up 75% of its $572M portfolio in Q4 2023.
  • USA Financial Formulas opened 76 new positions and closed 237 in Q4 2023.
  • USA Financial Formulas's portfolio value rose 754% quarter-over-quarter to $572M.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.